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Abstract
Biologically monitoring marijuana exposure from active and passive use requires both a wide 
linear range and sensitive detection. We have developed and validated a multifunctional method 
using ultrahigh performance liquid chromatography coupled with tandem mass spectrometry 
(UHPLC–MS/MS) for analysis of urinary Δ9-tetrahydrocannabinol (THC), cannabidiol and 
cannabinol, and two major metabolites of THC, 11-nor-9-carboxy-THC and 11-hydroxy-THC, in 
active users and particularly in people exposed to secondhand marijuana smoke (SHMS). The 
method used positive electrospray ionization (ESI) mode to reach the sensitivity needed to detect 
trace SHMS exposure with limits of detection (LOD) ranging from 0.002 to 0.008 nanograms per 
milliliter (ng/mL) and 0.005 to 0.017 ng/mL for “free” (unconjugated forms) and “total” 
(unconjugated plus conjugated forms) measurements, respectively. These LODs were 
approximately 10–100 times more sensitive than those reported in the literature. To reduce or 
avoid time-consuming repetitive sample preparation and analysis, the method simultaneously 
monitored multiple reaction monitoring transitions in negative ESI mode to quantify high analyte 
levels typically found in the urine of active marijuana users (linear dynamic range of 12.5–800 ng/
mL). The validation results indicated this method was accurate (average inter/intra-day bias, 
<10%), precise (inter/intra-day imprecision, <10%), and fast (6 min run time). In addition, sample 
preparation throughput was greatly improved using an automation liquid-handling system, meeting 
the needs for potential large-scale population studies.
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Increasing use of marijuana both medicinally and recreationally1,2 may lead to increased 
health risks resulting from exposure to both cannabinoids and the toxic chemicals found in 
marijuana smoke.3–5 Traditionally, cannabinoids and their metabolites, i.e., Δ9-
tetrahydrocannabinol (THC), cannabidiol (CBD) and cannabinol (CBN), and two major 
metabolites of THC, 11-nor-9-carboxy-THC (COOH-THC) and 11-hydroxy-THC (OH-
THC) (Figure S-1), are measured in the urine of people to assess their exposure to marijuana 
products and smoke.
In the last decades, a number of analytical methods have been applied to analyze THC, OH-
THC, COOH-THC, CBD, and CBN in urine samples, including methods employing liquid 
or gas chromatography (LC or GC) coupled with either a single quadrupole mass 
spectrometry (MS) or tandem mass spectrometry (MS/MS).6–10 Reported limits of detection 
(LOD) for these analytes ranged from 0.2 to 5.0 nanograms per milliliter (ng/mL). Given the 
relatively high exposure levels resulted from active marijuana smoking, these LODs meet 
the needs accordingly for desired detection rates. Nevertheless, persons smoking marijuana 
could also cause passive exposure of other people through inhalation of secondhand 
marijuana smoke (SHMS), which are often characterized by low biomarker levels although 
collectively depending on factors including environmental circumstances, smoker density, 
and exposure duration. While most studies have focused on active use of marijuana, 
information on SHMS, including exposure characteristics and adverse health consequences, 
is still limited in the open literature. A sensitive analytical method to quantify trace 
biomarker levels is therefore indispensable for effectively monitoring and assessing SHMS 
exposure.
The objective of this study was to develop and analytically validate a sensitive ultrahigh 
pressure LC (UHPLC)–electrospray ionization (ESI) combined with MS/MS method for 
quantifying THC, COOH–THC, OH–THC, CBD, and CBN in urine from people exposed to 
marijuana smoke, particularly to SHMS. To the best of our knowledge, the analyte-specific 
LODs achieved in this method for urine samples were approximately 10–100 times more 
sensitive than previous studies. In addition, time-consuming repetitive preparation and 
analysis of unknown urine samples often become necessary when analyte levels fall out of a 
method’s linear dynamic ranges. We simultaneously monitored multiple reaction monitoring 
(MRM) transitions of those five analytes under both positive and detuned negative ESI 
modes for low-concentration (LODs, 50 ng/mL) and high-concentration (up to 800 ng/mL) 
samples, respectively. This combined analysis greatly increased the applicable quantitation 
ranges and facilitated the data acquisition by reducing or avoiding potential repetitive sample 
preparation and analysis. Finally, we increased sample preparation throughput using an 
Wei et al. Page 2













automation liquid-handling system to meet the needs for potential large-scale population 
studies.
EXPERIMENTAL SECTION
Details on chemicals and materials are provided in the Supporting Information.
Standard Solution Preparation
Blank urine pools, used as a matrix for calibration standard (calibrators) and quality control 
(QC), were prepared using human urine anonymously collected in compliance with 
Institutional Review Board protocol. The CDC Human Subjects Review Board determined 
this activity was not a human subject research. Blank urine samples were combined to form 
a matrix urine pool, which was kept at 4 °C and stirred overnight to ensure thorough mixing. 
This urine pool was subsequently spiked with target analytes to form calibrators and QCs.
We prepared working solutions for calibrators and QCs from serial dilutions of primary 
stock solutions with methanol and water (v/v 60:40) and stored them in Teflon-capped 
amber glass vials at −24 °C. A volume of 50 µL of each working solution was automatically 
added to 500 µL of blank urine (see Sample Preparation), creating calibrators at 0.001 to 800 
ng/mL, and QC samples at 0.05, 25, and 500 ng/mL. The internal standard spiking solution 
had concentrations of 0.06 ng/µL for CBD-d3, CBN-d3 and 0.1 ng/µL for OH-THC-d3, 
COOHTHC-d3, and THC-d3. Details regarding the standard solution preparation are given 
in the Supporting Information.
Sample Preparation
We prepared calibrators, QCs, blanks, and unknown urine samples following same 
procedures, as depicted in Figure 1. Briefly, urine samples stored at temperatures ≤−65 °C 
were thawed and vortex-mixed for 10 min at room temperature. To measure “total” 
concentrations (unconjugated and conjugated forms), 500 µL of each urine sample (blank 
and unknown) was transferred to each well in the 96-well plate, followed by adding 50 µL of 
calibrator and QC working solutions to each blank urine sample. Working solutions were 
replaced with water for unknown samples. Then, 50 µL of internal standard solution and 50 
µL of enzyme solution (Escherichia coli, type IX-A, 20 units/µL, 0.5 M ammonium acetate, 
pH 6.8) were added into all samples. After gentle mixing (“Pre-Mix”), the 96-well plate was 
incubated at 37 °C for 2 h. Then, 50 µL of 10 N NaOH was added to each well and 
incubated at 70 °C for 20 min. After cooling the plate to room temperature, 400 µL of formic 
acid, water, and methanol (v/v/v 12.5:12.5:75) was added to each well. To measure “free” 
unconjugated concentrations, enzyme and NaOH solutions were replaced with 450 µL of 
formic acid, water, and methanol (v/v/v 5.5:27.8:66.7) and no incubation was performed. 
After mixing for 5 min, the plate was centrifuged for 30 min at −5 °C, and then 0.96 mL 
mixtures from each well was transferred onto the 96-well SPE plate, pre-equilibrated with 
1.0 mL of methanol and 1.0 mL of buffer (5 mM ammonium formate, 0.05% formic acid). 
After soaking for 10 min, the mixtures were pushed through the SPE under approximately 
1.0 psi positive pressure. Then, the samples were washed with 1.0 mL of water and 1.0 mL 
of methanol and water (v/v 60:40). After drying for 15 min with nitrogen (25 psi), the 
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samples were collected in a second 96-well plate by elution with 1.0 mL of methanol and 
then evaporated to dryness using a TurboVap evaporator (Biotage, Charlotte, NC) at room 
temperature. The residuals were reconstituted with 50 µL of method and water (v/v 50:50). 
After 5 min of vortex, 10 µL of each sample was injected into the LC system.
Instrumentation and Operation
The “Pre-Mix” procedure (Figure 1), also the critical one impacting the accuracy and 
precision of analytical results, was performed on a Hamilton automated liquid-handling 
system, Microlab Star (Reno, NV), aimed at improving data reproducibility and sample 
preparation throughput. On an as-needed basis in future, the throughput can be further 
expanded using a fully automated system illustrated in our previous study.11 Additional 
information can be obtained upon request.
Chromatographic separation was achieved using a Kinetex reversed phase column (100 mm 
× 2.1 mm, particle size 2.6 µm, C18) (Phenomenex, Torrance, CA) on a Shimadzu UHPLC 
system (Columbia, MD) at a flow rate of 0.4 mL/min. Column temperature was maintained 
at 40 °C during the entire analysis. The gradient program contained 5.0 mM of ammonium 
formate with 0.05% formic acid (solvent A) and acetonitrile (solvent B). After injection, LC 
flow during the first 2.5 min and the last 1.5 min was directed to a waste container by the 
switching valve. Only the flow occurring between 2.5 and 4.5 min was directed to the MS. 
Detailed gradient conditions are provided in Table S-1. Figures 2a,c,e,g,i and 2b,d,f,h,j) 
depict representative chromatograms for urine samples processed with the “free” and “total” 
methods, respectively.
MS/MS analysis was performed on a Sciex triple quadrupole 6500 with a TurboIonSpray 
source (Foster City, CA). ESI+ and ESI− modes were used to acquire scheduled MRM 
transition data. Optimum MS source parameters were as follows: source temperature, 
600 °C; ionspray voltage (ESI+/ESI−), 5500/–4500 V; ion source gas-1, 80 psi, and gas-2, 90 
psi; curtain gas, 35 psi; target scan time (ESI+/ESI−), 0.18/0.041 s. Two MRM precursor/
product transitions for each native analyte and one transition for the isotope labeled internal 
standard were monitored. The collision offset energy (CE) under ESI− mode was “de-tuned” 
to higher value so as to yield a lower response of the corresponding MRM transition to avoid 
detector saturation when analzying high concentrations typically found in active smokers’ 
urine. Detailed MRM transitions and voltage settings are given in Table S-2, and the 
instrument method for data acquisition is also described in the Supporting Information.
RESULTS AND DISCUSSION
We first evaluated different 96-well plates containing various materials, including C18, 
mixed-mode cation/anion-exchange polymer, strongly hydrophilic water wettable polymer, 
and inert diatomaceous earth. Overall, C18 SPE provided the highest sample extraction 
recoveries. The high lipophilicity of these analytes enabled us to apply high percentages of 
methanol in washing solvent (50–70%) to purify the urine samples on C18 SPE plates. We 
found washing solvent with methanol and water (v/v 60:40) had a balanced performance 
between extraction recoveries and matrix effects.
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Because ESI+ analysis yielded higher sensitivity for all analytes, we monitored their MRM 
transitions using ESI+ for low-concentration samples (LOD–50 ng/mL). To avoid variation 
caused by MS detector saturation using ESI+ analysis, we simultaneously monitored those 
five analytes under ESI− mode to quantify any unknown samples whose concentrations were 
in the range of 12.5–800 ng/mL. Under both ionization modes, we observed excellent 
calibration linearity with average determination coefficients (R2) ≥ 0.995. We also assessed 
data consistency between two ionization analyses by comparing fortified samples whose 
concentrations fell into the overlapping linear dynamic ranges of two modes, and we 
observed excellent agreement in analytical results (Table 2 and Table S-4). Expectedly, this 
combined analysis would greatly facilitate data acquisition by increasing the applicable 
dynamic ranges and reducing the repeating rates of sample preparation and analysis.
One of the challenges in measuring urinary cannabinoids and their metabolites is that the 
high lipophilicity of these compounds can result in substantial adsorption to materials used 
for sample preparation, i.e., tips and 96-well plates. To minimize chemical loss during 
sample preparation, we added 0.3 mL of methanol into all samples before SPE cleanup. 
After injection, the analytes could also absorb to other instrumental surfaces, i.e., tubing, 
column, LC injection loop, needle, and port, etc. Over time, amounts accumulated on LC 
parts can potentially cause carry-over contamination. To avoid this issue, we added the 
following LC autosampler washing program: before each injection, the autosampler 
measuring line was washed with 600 µL of acetonitrile and water (v/v 55/45), and both 
internal and external surfaces of the sampling needle were rinsed with 300 µL of acetonitrile, 
2-propanol, and water (v/v/v 45/45/10). We evaluated the effectiveness of this washing 
program by measuring the carry-over concentrations in the subsequent blank urine samples 
following the processed highest calibrator (800 ng/mL). The results indicated that no 
targeted peaks at the retention times of all analytes were detected.
Thermal instability of these analytes in urine was another issue that requires extra caution in 
the entire processes of sample collection, transport, storage, and analysis. Our stability tests 
with fortified urine at room temperature (~25 °C) indicated >80% of total CBD, CBN, and 
THC were lost after 24 h (Figure 3b,d,f). The losses of total OHTHC and COOH-THC at 
25 °C were approximately 5 and 12% after 24 h, respectively. At 4 °C, approximately 10–
30% of total CBD, THC, and CBN decomposed after 3 days, and no obvious losses of total 
OHTHC and COOH-THC were observed (Figure 3a,c,e). We did not observe a significant 
decrease in total analyte concentrations ≤−20 °C during the same study period. These results 
are consistent with those reported in a recent study by Desrosiers et al.12 Studies regarding 
long-term stability at temperatures ≤−20 °C and the stability to indoor light are in progress. 
Available evidence indicated that urine samples should always be kept frozen during storing 
and shipping. For analysis, samples need to be prepared in a timely manner and analyzed 
within 1 day. The high-throughput liquid-handling automation system and fast UHPLC–
MS/MS analysis (~two 96-well plates/instrument/day) presented in this study would better 
meet such needs so as to maintain the quality of analytical results.
One of the main advantages of this method, aside from the broad applicable quantitation 
ranges, high-throughput preparation, and fast analysis, is the marked sensitivity that is 
essential for effectively monitoring and assessing SHMS exposure. We determined the 
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LODs and limits of quantitation (LOQ) by preparing and analyzing four low-concentration 
urine pools (0.005, 0.010, 0.025, and 0.050 ng/mL) over a 3-month period. We first 
determined the standard deviation (SD) of each pool’s concentration quantified using first 
MRM transition with confirmation by the second transition (Table S-2) (More details 
regarding analytical specificity is described in the Supporting Information), and then we 
plotted the SD of each pool against the concentration, and finally obtained the S0 given as 
the Y-intercepts.13–15 LODs and LOQs (Table 1) were calculated as 3S0 and 10S0, 
respectively. We observed the method for unconjugated form had more sensitive LODs 
(0.002–0.008 ng/mL or equivalently 0.064–0.242 fmol on-column) than those for “total” 
form (0.005–0.017 ng/mL or equivalently 0.159–0.514 fmol on-column) (Table S-3). This 
was most likely the result of the tandem-hydrolysis procedure (enzymatic-alkaline 
hydrolysis). During hydrolysis incubation at higher temperature, analytes can partially 
degrade due to their thermal instability; meanwhile, they can also partially bind to added 
enzyme (E. coli.) because of the high lipophilicity and then precipitate by centrifugation. 
Despite the mass loss during sample preparation, the detection sensitivity achieved in this 
method for urine samples were 10–100 times the values (0.2–5.0 ng/mL) reported in the 
literature.6–9
We used three sets of samples at low, medium, and high concentrations (0.025, 25, and 500 
ng/mL, respectively) to determine the optimized extraction recoveries and matrix effects 
(details in the Supporting Information).11 Average extraction recoveries for all analytes 
ranged from 54 to 93% and 18 to 75% for “free” and “total” measurements, respectively 
(Table 1). Ion suppression due to matrix effect varied from −9 to 32 and −41 to 32 for “free” 
and “total” measurements, respectively.
Calibrators and QCs were always freshly produced using the liquid-handling automation 
system and then prepared in the same manner along with unknown samples and laboratory 
blanks. We observed excellent interday and intraday accuracy (90–110%), and imprecision 
was less than 10% (Table 2 and Table S-4) based on replicate analyses of a serial of fortified 
urine samples prepared by spiking known amounts of analytes over 3 consecutive months.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Sampling preparation scheme. Abbreviations: ISTD, internal standard spiking solution; 
Conc., concentration. “Pre-Mix” included adding ISTD and enzymatic solution (if 
measuring “total” concentration) to urine samples followed by gentle mixing. “Hydrolysis” 
included enzymatic and alkaline procedures in order and was omitted to measure “free” 
(“unconjugated”) concentrations. “SPE Extraction” included SPE pre-equilibrium sample 
cleanup and elution.
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Chromatograms of fortified urine samples analyzed on the Sciex triple quadrupole 6500. 
Chromatograms illustrated in left column (0.010 ng/mL) and right column (0.025 ng/mL) 
were for “free” (“unconjugated”) and “total” (“conjugated” + “unconjugated”) 
concentrations, respectively.
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Thermal stability of OHTHC, COOH-THC, CBD, CBN, and THC in fortified urine pools. 
Parts a, c, and e show the results for samples stored at 4 °C and parts b, d, and f display the 
results for samples stored at 25 °C.
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